药物监测项目与健康信息技术的互补性对减少阿片类药物相关死亡率和发病率的影响

The complementarity of drug monitoring programs and health IT for reducing opioid‐related mortality and morbidity

Health Economics · 2021
被引 15
人大 A-

中文导读

研究美国各州将处方药监测项目与健康信息技术整合的政策,发现该整合能显著降低阿片类药物相关的住院发病率,尤其对未强制使用监测项目的州和弱势群体效果明显。

Abstract

In response to the opioid crisis, each US state has implemented a prescription drug monitoring program (PDMP) to collect data on controlled substances prescribed and dispensed in the state. I study whether health information technology (HIT) complements patient prescription data in PDMPs to reduce opioid-related mortality and morbidity. A novel dataset is constructed that records state policies that integrate PDMP with HIT and facilitate interstate data sharing. Using difference-in-differences models, I find that PDMP-HIT integration policies reduce opioid-related inpatient morbidity. The reductions are substantial in states that established integration without ever mandating the use of a PDMP. A mechanism test suggests that PDMP integration works mainly through the hospital system while a mandate affects legal opioids prescription. The impacts from integration are strongest for the vulnerable groups-middle-aged, low-to middle-income patients, and those with public insurance. There is suggestive evidence that interstate data sharing further complements integration despite not having a significant impact independently. The results are robust to a set of tests using alternative specifications and measures. The total benefits from integration far exceed the associated costs.

处方药监测计划健康信息技术阿片类药物死亡率发病率